Press Releases

Carbohydrates of BOC Sciences Reveal Myriad Possibilities for Therapeutics

BOC Sciences updated several carbohydrates and derivatives in July 2020 and has kept a constant enlargement of product categories since then. Currently, it provides a full spectrum of carbohydrates that dramatically boost the research in Glycochemistry, Glycobiology, Glyco-analytics, and other Glycosciences.

BOC Sciences Officially Releases the Final Invitation to Renowned Pharma Conferences in May

As the two industry-renowned exhibitions—CPhI North America and TIDES USA 2022 draw near, BOC Sciences is making final efforts to let the news reach as many researchers as possible, especially those who are struggling to find the best mRNA services.

BioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease Project

BioIVT is sourcing matched sets of cerebrospinal fluid, serum, and plasma from donors afflicted with ALS to further research of neurofilament in the blood as a biomarker for early stages of neurodegeneration.

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

Cytel designed and led TOGETHER Trial wins Society of Clinical Trial's David Sackett Trial of the Year Award

The TOGETHER Trial for COVID-19 therapies, designed by clinical trial specialists at Cytel, has just won the Society for Clinical Trial’s annual Trial of the Year Award for 2021.

Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics

Beacon Biosignals, which applies AI to EEG to unlock precision medicine for brain conditions, today announced a partnership with Stratus, the nation’s leading provider of EEG services, to enable expanded clinical trial service capabilities by leveraging Beacon’s machine learning neuroanalytics platform.

Domain registration,Hosting,Sites on Wordpress,Cloud VPS,SSL certificates,Servers,DC,Wordpress,Data centers

[url=https://www.reg.ru/?rlink=reflink-7347627] Domain registration [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] hosting [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] sites on wordpress [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] cloud vps [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] ssl certificates [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] servers [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] dc [/url] [url=https://www.reg.ru/?rlink=reflink-7347627] data centers[/url] ...

Tjoapack doubles packaging capacity with completed Netherlands facility expansion

Global pharmaceutical contract packaging organisation (CPO), Tjoapack has announced the completion of its expansion plans following a €10m+ plus investment at its Etten-Leur facility in the Netherlands.

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member Former Vice Dean at East Carolina University’s Brody School of Medicine brings scientific and strategic expertise to lead the federally funded clinical research enterprise of this international CRO. Research Triangle Park, NC – April 19, 2022 – Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, has appointed Peter Schmidt, Ph.D., as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division. For over 30 years, Rho has worked closely with NIH/NIAID and other federal departments on groundbreaking clinical trial and epidemiologic studies, including the LEAP peanut allergy study. “I am thrilled to welcome Dr. Schmidt to Rho," said Dr. Laura Helms Reece, CEO, Rho. “He is a preeminent neuroscientist and recognized leader across federal, commercial and academic arenas. His expertise in clinical research is remarkable, and his command of central nervous system, infectious disease, and other indications is a great fit with Rho’s focus in those areas. I am eager to work with Dr. Schmidt as he brings exciting strategic and scientific leadership to our federal business. His experience and judgment will be great additions to our Executive Committee.”

Bora Pharmaceuticals to expand operations with $10m+ investment

Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library

Creative Peptides constructed a versatile total peptide library with its proprietary peptide design platform to accelerate peptide drug research.

BOC Sciences Unveils Comprehensive Custom Synthesis Services

BOC Sciences unveils its comprehensive custom synthesis services for worldwide partners engaged in biopharmaceutical, chemical, and life science research.

List Bio Raises $48.4 Million Series A for Global Scale-Up

List Bio will use an $48.4 million Series A investment to build a large-scale manufacturing facility in Fishers, Indiana, USA

Panthera Biopartners raises £10 million to accelerate its dedicated clinical trial site expansion across the UK and Western Europe

Panthera Biopartners has secured £10 million of investment from BGF and Gresham House Ventures, the latter investing on behalf of the Baronsmead VCTs. This investment round will be used to fund further expansion in the UK and Western Europe.

DNDi and BenevolentAI collaborate to accelerate life-saving drug discovery research in dengue

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions

Rho Experts Share How Customized Data Visualization Platform Provides Sponsors Real-time Study Data to Inform Decisions Global CRO to demonstrate how data visualization can improve the conduct of clinical trials in a free webinar WHAT: Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, will discuss how ongoing access to real-time clinical study data and metrics is essential for efficient start-up and conduct of clinical trials in an upcoming webinar, “Using Advanced Data Visualization to Power Up Clinical Trials.” The webinar will take place on Wednesday, April 27, from 2-3 p.m. EST.

Creative Enzymes to Exhibit at the PEGS Boston Summit on May 2-6, 2022

Tower Cold Chain wins Queen’s Award for International Trade

For more information on Tower Cold Chain, visit https://bit.ly/3MicrTr

NorthX Biologics signs GMP manufacturing collaboration agreement with Abera Bioscience

Sweden-based NorthX Biologics (“NorthX”), which focuses on process development and large-scale production of advanced biological drugs, has signed a collaboration agreement with Abera Bioscience (“Abera”) for upscaling and GMP manufacturing of its vaccine candidate against pneumococcus, Ab-01.12.

Curebase selected to launch a clinical investigation of a digital therapeutic for IPF

Curebase selected to launch a clinical investigation of a digital therapeutic for IPF